MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,816,156 | -20.5% | 152,410 | -34.9% | 0.04% | -14.0% |
| Q2 2023 | $6,060,513 | +25.3% | 234,268 | +16.3% | 0.04% | +16.2% |
| Q1 2023 | $4,837,148 | +23.2% | 201,380 | 0.0% | 0.04% | +23.3% |
| Q4 2022 | $3,926,910 | +16.8% | 201,380 | +25.8% | 0.03% | +7.1% |
| Q3 2022 | $3,362,000 | +5.1% | 160,037 | -2.6% | 0.03% | +16.7% |
| Q2 2022 | $3,199,000 | -15.5% | 164,387 | -4.4% | 0.02% | -4.0% |
| Q1 2022 | $3,786,000 | -17.1% | 171,915 | -39.9% | 0.02% | -13.8% |
| Q4 2021 | $4,566,000 | – | 286,240 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |